Vaccine as a remedy for antimicrobial resistance; what are the Pros and Cons?

• Authors: Ibrahim Idris , Ridwan Olamilekan Adesola
• Languages of publication: EN

Abstracts

EN

Before microorganisms were discovered as the causative agents of diseases, it was taught that diseases occur as a result of an imbalance in energy channels within the body system. With the advent of antimicrobials drugs to cure these diseases in both humans and animals, these antimicrobial drugs turn out to be ineffective as a result of overuse and misuse that lead to antimicrobial resistance. Antimicrobials resistance is a silent pandemic having high morbidity and mortality that result in the death of over 1.2 million people worldwide as of 2019. Antimicrobial drugs are meant to prevent and treat disease but as a result of irrational usage, they pose great risks to humans, animals, and also the environment. This resistance is the major cause of persistent diseases and there is a need to avert its transmission and prevent further occurrence through a multidisciplinary approach, approaches to vaccine design and development, and also strengthening health care services delivery.

Keywords

EN

Antimicrobial drugs; Antimicrobial resistance; Cons; Pros; Vaccines

Discipline

• VETERINARY_MEDICINE: VETERINARY MEDICINE

• Publisher: Scientific Publishing House „DARWIN”
• Journal: World News of Natural Sciences
• Year: 2022
• Volume: 42
• Pages: 76-84

Contributors

author

Ibrahim Idris

• Department of Veterinary Medicine, Faculty of Veterinary Medicine, Usmanu Danfodiyo University, Sokoto, Nigeria

author

Ridwan Olamilekan Adesola

• Department of Veterinary Medicine, Faculty of Veterinary Medicine, University of Ibadan, Ibadan, Oyo State, Nigeria

References

• [1] Absar T., Asad U.K. Vaccines against antimicrobial resistance: a promising escape route for multidrug resistance. Pharmaceutical Patent Analyst 10(2) (2021) 83-98
• [2] Anderson E., Lewis M. Drug Resistance and its Transfer in Salmonella Antibiotic resistance—the need for global solutions typhimurium. Nature 206 (1965) 579-583
• [3] Calderon Diaz J.A., O'Neill L., da Costa M.R., Manzanilla E.G. 211 Biosecurity practices associated with antimicrobial usage in farrow-to-finish pig farms. Journal of Animal Science 98 (Suppl 3) (2020) 5-6
• [4] Christopher J.M., Kevin S.I., Fablina S., Lucien S., Gisela R. A., Authia G., Chieh H., Catherine B., Puja R., Eve W., Sarah C.J., Annie J. B. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. The Lancet 399 (10325) (2022) 629-655
• [5] Corneliu O.V., Laura I.P., Coralia B., Mariana C.C. Targeting Plasmids to Limit Acquisition and Transmission of Antimicrobial Resistance. Frontier in Microbiology 11 (2020) 761
• [6] Crotty S., Follicular helper CD4 T cells (TFH). Follicular Helper CD4 T Cells (TFH). Annual Review of Immunology 29 (2011) 621-663
• [7] David P., Clark N.J., Pazdernik M.R. A plasmid (pLau53) producing C-terminal CFP and YFP fusions of LacI and TetR, respectively, under the control of the arabinose promoter from pBAD has been constructed. Molecular Biology 3 (2019) 971-1001
• [8] Francesca M., Fabio B., Rino R. Davide S. Role of vaccines in combatting antimicrobial resistance. Nature Reviews Microbiology 19 (2021) 287-302
• [9] Francesca P., Patrizio P., Annalisa P. Antimicrobial resistance: a global multifaceted phenomenon. Pathog Glob Health. 109 (7) (2015) 2047-7724
• [10] Forder A.A. A brief history of infection control - past and present. South African medical journal 97(11) (2007) 1161-1164
• [11] Holmes A.H., Moore L.S., Sundsfjord A., Steinbakk M., Regmi S., Karkey A., Guerin P.J., Piddock L.J. Understanding the mechanisms and drivers of antimicrobial resistance. Lancet (London, England) 387(10014) (2016) 176-187
• [12] Hughes V.M., Datta N. Conjugative plasmids in bacteria of the ‘pre-antibiotic’ era. Nature 302 (1983) 725-726
• [13] Kothari C., Gaind R., Singh L.C., Sinha A., Kumari V., Arya S., Chellani H., Saxena S., Deb M. Community acquisition of β-lactamase producing Enterobacteriaceae in neonatal gut. BMC Microbiol 13 (2013) 136
• [14] Lipsitch M, Siber GR. How can vaccines contribute to solving the antimicrobial resistance problem? ASM Jounal 7 (3) 2016
• [15] Michael J.F. Recent Advances in Vaccine Technologies. Veterinary Clinics of North America: Small Animal Practice 48 (2) (2018) 231-241
• [16] Serge Morand, K. Marie McIntyre, Matthew Baylis. Domesticated animals and human infectious diseases of zoonotic origins: Domestication time matters. Infection, Genetics and Evolution, Volume 24, 2014, Pages 76-81, https://doi.org/10.1016/j.meegid.2014.02.013
• [17] Mukhlesur R., Satyajit D.S. Antimicrobial natural products; A Disease-Focused Approach. Annual Reports in Medicinal Chemistry 55 (2020)
• [18] Ramanan L., Adriano D., Chand W., Anita K.M., Heiman F.L.W., Nithima S., Erika V., Gabriel L. H. Antibiotic resistance - the need for global solutions. The Lancet 13 (12) (2013) 1057-1098
• [19] Ryan F.D. Vaccine delivery systems. Human Vaccines & Immunotherapeutics 13 (1), (2017) 17-18
• [20] Plotkin Stanley. History of vaccination. Proc Natl Acad Sci U S A. 2014 Aug 26; 111(34): 12283-7. doi: 10.1073/pnas.1400472111
• [21] Plotkin Stanley. Vaccines: life savers and controversy makers. The Lancet 369(9571) (2008) 1421-1422. DOI: https://doi.org/10.1016/S0140-6736(07)60652-7
• [22] Stephany R. W. Hormonal growth promoting agents in food producing animals. Handbook of Experimental Pharmacology (195) (2010) 355-367
• [23] Walsh T.R., Weeks J., Livermore D.M., Toleman M.A. Dissemination of NDM-1 positive bacteria in the New Delhi environment and its implications for human health: an environmental point prevalence study. The Lancet 11(5) (2011) 355-362
• [24] Wellington E.M., Boxall A.B., Cross P., Feil E.J., Gaze W.H., Hawkey P.M., Johnson-Rollings A.S., Jones D.L., Lee N.M., Otten W., Thomas C.M., Williams A.P. The role of the natural environment in the emergence of antibiotic resistance in gram-negative bacteria. The Lancet 13(2) (2013) 155-165
• [25] Zhu J., Yamane H., Paul W.E. Differentiation of effector CD4 T cell populations. Annual Review of Immunology 28 (2010) 445-489

• Document Type: article